XML 41 R30.htm IDEA: XBRL DOCUMENT v3.25.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Schedules of Concentration of Credit Risk

Schedules of Concentration of Credit Risk 

  

June 30,

2025

  

December 31,

2024

 
Customer A   52%   -* 
Customer B   46%   -* 
Customer C   -*    36%
Customer D   -*    17%
Customer E   *    15%

 

*   Accounts Receivable was less than 10%
Schedules of Financial Instruments Fair value Hierarchy

The following table summarizes the Company’s financial instruments at fair value based on the fair value hierarchy for each class of instrument as of June 30, 2025:

 

   Level 1   Level 2   Level 3   Total 
Convertible notes payable  $   $   $19,434,004   $19,434,004 
Schedules of Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation

The Company calculated the estimated fair value of the convertible notes payable during the six months ended June 30, 2025 using the following assumptions: 

 

Issuance date  2/10/2025 
Maturity date  5/10/2026 
Stock price   5.88 - 7.45 
Expected volatility factor   124.8 - 128.3%
Risk-free interest rate   4.02 - 4.25%
Schedules of Changes in Convertible Notes Payable Measured at Fair Value

The following table presents changes in the Level 3 convertible notes payable measured at fair value for the six months ended June 30, 2025:

 

      
Balance, January 1, 2025  $ 
Additions   14,432,879 
Fair value measurement adjustments   6,864,056 
Loss on extinguishment   4,623,335 

Redemption

   

(1,650,000

)
Conversion into common stock   (4,836,266)
Balance, June 30, 2025  $19,434,004 
Schedules of Revenue Disaggregated by Revenue Type

The following table presents the Company’s revenue disaggregated by revenue type:

 

               2025   2024 
   

Three months ended

June 30,

 

Six months ended

June 30,

 
    2025     2024    2025   2024 
Product related   $ 2,090,278     $ 3,208,870    $3,719,940   $9,822,899 
Contract related     1,128,299       3,210,799     1,128,299    3,210,799 
Total   $ 3,218,577     $ 6,419,669    $4,848,239   $13,033,698 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

  

June 30,

2025

  

December

31, 2024

 
Series B Preferred Stock, as converted   3,896    3,896 
Stock options   5,317,060    5,242,308 
Warrants   1,631,433    914,056 
Restricted stock   2,009,841    1,544,027 
Total   8,962,230    7,704,287